How much funding has Longeveron LLC raised?

Longeveron LLC has raised $15.0M in total funding, most recently a Corporate Round.

When was Longeveron LLC founded?

Longeveron LLC was founded in 2017.

Where is Longeveron LLC headquartered?

Longeveron LLC is headquartered in MIAMI, Florida, United States.

What industry is Longeveron LLC in?

Longeveron LLC operates in Biotech, Clinical Stage, Healthcare.

How many employees does Longeveron LLC have?

Longeveron LLC has 1-10 employees.

Longeveron LLC

Q: Who are Longeveron LLC's investors?

Longeveron LLC's investors include Coastlands Capital, Janus Henderson Investors, Logos Capital.

IPO

Advancing Cell-Based Therapies for Aging and Disease

MIAMI, United States · Founded 2017 · $15.0M raised

Biotech

Clinical Stage

Healthcare

Headquarters: MIAMI, Florida
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: longeveron.com
Total Funding: $15.0M
Last Round: $15.0M Corporate RoundMar 2026
Rounds: 1

About

Longeveron is a clinical-stage regenerative medicine company developing mesenchymal stem cell therapies for aging-related and life-threatening conditions. Its lead product, laromestrocel (Lomecel-B™), is derived from bone marrow of healthy adult donors and is being evaluated in clinical trials for Alzheimer's disease, aging-related frailty, hypoplastic left heart syndrome, and pediatric dilated cardiomyopathy. The company operates a GMP manufacturing facility in Miami, Florida.

Summary

Longeveron LLC is a Biotech company based in MIAMI, United States, founded in 2017. It has raised $15.0M in total across 1 round, most recently a $15.0M Corporate Round round in Mar 2026. Investors include Coastlands Capital, Janus Henderson Investors and Logos Capital.

LinkedIn X (Twitter)